Wound Healing and Surgical Complications

Mechanism 1 — Bacterial burden and wound class

• Degree of contamination: the CDC wound classification (clean, clean-contaminated, contaminated, dirty/infected) tracks with SSI risk; entry into the colon, an unprepped viscus, or frank pus at the time of incision seeds the wound beyond the threshold the innate immune system can clear.
• Endogenous flora: Staphylococcus aureus (including MRSA colonization of the nares) and skin streptococci dominate clean cases; polymicrobial gram-negative and anaerobic flora dominate colorectal and biliary cases.

Normal Wound Healing Phases

• Hemostasis (immediate to minutes): Platelet aggregation and coagulation cascade activation form a fibrin clot; tissue factor (TF) and thrombin initiate coagulation while platelets release growth factors including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β)

• Inflammatory Phase (0-3 days): Neutrophils (first responders) and macrophages (predominant by day 2-3) migrate via chemotaxis; macrophages release cytokines (TNF-α, IL-1, IL-6) and growth factors (VEGF, FGF, TGF-β); this phase is essential for clearing debris but excessive inflammation impairs healing

• Proliferative Phase (3-21 days): Fibroblasts synthesize extracellular matrix (collagen types I and III); angiogenesis occurs via VEGF-mediated capillary formation; re-epithelialization progresses with epithelial cells migrating across the wound bed; wound strength increases from ~5% at day 3 to ~50% by day 21

• Remodeling/Maturation Phase (21 days to 2+ years): Collagen is reoriented and cross-linked while type III collagen is gradually replaced by stronger type I collagen; matrix metalloproteinases (MMPs) remodel extracellular matrix; maximum tensile strength (~80% of unwounded skin) is achieved around 60 days but continues improving for up to 2 years

Molecular Mediators of Wound Healing

• TGF-β and PDGF stimulate fibroblast recruitment and collagen synthesis
• VEGF and FGF promote angiogenesis and endothelial cell proliferation
• Matrix metalloproteinases (MMPs) degrade extracellular matrix; tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity
• Nitric oxide enhances vasodilation and inflammatory cell recruitment
• Growth hormone, thyroid hormone, and vitamin C are cofactors for collagen synthesis

Impaired Healing Mechanisms

• Infection: Bacterial colonization (>10⁵ organisms/gram tissue) overwhelms immune response, producing proteases and inflammatory mediators that destroy matrix
• Ischemia: Reduced oxygen tension impairs oxidative killing by neutrophils, decreases collagen deposition, and reduces angiogenesis
• Malnutrition: Deficiencies in protein, vitamin C, zinc, and arginine impair fibroblast function and collagen cross-linking
• Chronic inflammation: Prolonged inflammatory phase (seen in diabetes, venous/arterial insufficiency) delays transition to proliferative phase
• Excessive tension: Mechanical stress disrupts neovascularization and increases risk of dehiscence

Early Wound Complications (First Few Days to Weeks)

• Surgical Site Infection (SSI): Erythema, warmth, swelling, purulent drainage, fever, and systemic signs appearing >48 hours post-op; differentiate from normal inflammatory response; superficial incisional SSI affects skin/subcutaneous tissue only, while deep incisional SSI involves fascia/muscle, and organ/space SSI involves organs manipulated during surgery

• Wound Dehiscence: Partial or complete separation of wound edges typically occurring 5-10 days post-op; presents with sudden drainage increase, visible separation, and "pink-tinged" serosanguineous fluid; evisceration (complete fascial separation with organ protrusion) is a surgical emergency

• Hemorrhage: Abnormal bleeding from wound (distinguish primary hemorrhage <24 hours from secondary hemorrhage 5+ days post-op); presenting with blood-soaked dressings, hemodynamic instability, falling hemoglobin

Late Wound Complications (Weeks to Months)

• Hypertrophic Scar: Excessive collagen deposition within original wound boundaries; remains red, raised, and pruritic for months; more common on chest, shoulders, and joints; generally regresses over 12-18 months but slower than normotrophic scars

• Keloid Formation: Collagen proliferation extending beyond original wound margins into surrounding normal skin; darker skin types (Africans, Asians) at 15-fold increased risk; does not regress spontaneously and may recur after treatment; often painful or pruritic

• Contracture: Progressive wound contraction beyond normal healing; mediated by myofibroblasts (fibroblasts expressing α-smooth muscle actin); particularly problematic over joints and can cause significant functional impairment

• Sinus Tract and Fistula Formation: Abnormal epithelialized tract (sinus) or communication between organs/tissues (fistula); suggests inadequate drainage or foreign body; may present with persistent drainage or recurrent localized infection

Important Clinical Pearls About Presentation

• Normal post-operative erythema, mild warmth, and serous drainage for first 48 hours do NOT indicate infection
• Wound separation is often preceded by minor drainage increase—early recognition prevents full evisceration
• Dark-skinned patients at higher risk for keloid and hypertrophic scarring; should avoid elective surgery when possible and consider preventive treatments

Clinical Assessment

• Physical examination: Inspect for erythema, warmth, fluctuance, drainage characteristics (serous vs. purulent), wound separation, crepitus (suggests gas-forming organisms); palpate for induration, fluctuance, and lymphadenopathy; assess surrounding skin for cellulitis

• Timing of presentation: SSI typically manifests >48 hours post-op; earlier infections (within 24 hours) suggest aggressive organisms (Group A Streptococcus, Clostridium); consider non-infectious causes (allergic reaction, hematoma) if presentation inconsistent with infection

Laboratory and Microbiologic Diagnosis

• Wound culture and gram stain: Gold standard for SSI diagnosis; obtain by swab (superficial) or aspiration (deep infection); culture identifies causative organism and guides antibiotic therapy; gram stain provides rapid morphologic information and guides empiric coverage while awaiting culture results

• Complete blood count (CBC): Elevated WBC count suggests infection but is non-specific; may see left shift (bands >10%) with systemic infection; helpful for identifying immunocompromise if WBC significantly low

• Inflammatory markers: Procalcitonin and C-reactive protein (CRP) elevated with infection but non-specific; may be elevated post-operatively even without infection; useful for monitoring treatment response

Imaging

• Ultrasound or CT: Identifies fluid collections, abscess formation, and deep space involvement; ultrasound preferred as first-line for most surgical wounds due to cost and availability; CT better for complex anatomy (abdomen/pelvis)

• Fistulography or sinography: Injected contrast outlines sinus tract or fistula path; helpful for planning surgical management in chronic cases

Important Diagnostic Considerations

• Do NOT obtain cultures for simple erythema without drainage; cultures are indicated for purulent drainage, fluctuance, signs of systemic toxicity, or failure to improve with conservative measures
• Distinguish cellulitis (spreading erythema, no abscess) from abscess formation (localized fluctuance); abscesses require drainage while cellulitis alone may respond to antibiotics
• β-hemolytic streptococci and Staphylococcus aureus account for majority of superficial SSIs; consider MRSA in high-risk patients or healthcare-associated infections

First-Line Treatment for Surgical Site Infections

• Empiric antibiotic coverage: Start immediately upon suspicion, do not wait for culture results; for

Infectious

• Surgical site infection: bacterial proteases and neutrophil enzymes degrade the provisional matrix; signaled by purulence, spreading erythema, and fever typically after postoperative day 4-5. Superficial SSI is managed by opening the incision and drainage, with antibiotics reserved for cellulitis or systemic signs per the IDSA skin and soft tissue infection guideline.
• Necrotizing soft tissue infection — EMERGENCY: fascial-plane spread with thrombosis of perforating vessels; pain out of proportion to exam, bullae, crepitus, skin anesthesia, dishwater-gray drainage, and rapid systemic toxicity. Treatment is immediate operative debridement plus broad-spectrum antibiotics with a protein-synthesis inhibitor (clindamycin) for toxin suppression; imaging must never delay the OR.
• Toxic shock syndrome — EMERGENCY: superantigen-mediated; a bland-looking wound with fever, diffuse erythroderma, and shock.
• Clostridioides difficile colitis: a complication of the treatment — perioperative and therapeutic antibiotics.

Mechanical

• Dehiscence and evisceration — EMERGENCY: fascial closure fails around days 5-10, when wound strength is still low; heralded by a sudden gush of salmon-colored serosanguineous fluid. Evisceration requires moist saline gauze coverage, NPO status, and urgent return to the OR.
• Incisional hernia: the late sequela of subclinical fascial dehiscence; a reducible bulge at the scar, at risk for incarceration.
• Hematoma/seroma: dead space and oozing create a culture medium and separate tissue planes; fluctuant, non-erythematous swelling that raises infection and dehiscence risk.

Chronic and cosmetic

• Enterocutaneous fistula: persistent enteric drainage; suspect distal obstruction, foreign body, infection, or Crohn disease.
• Keloid and hypertrophic scar: excess TGF-β-driven collagen; intralesional corticosteroid, the mainstay, itself causes dermal atrophy, telangiectasia, and hypopigmentation.
• Contracture from myofibroblast-mediated shortening across joints, and Marjolin ulcer — squamous cell carcinoma arising in a chronic wound or burn scar, signaled by heaped-up nonhealing edges.

• Salmon/pink serosanguineous drainage on postoperative day 5-10 is fascial dehiscence until proven otherwise: the single best next step for frank evisceration is cover with moist sterile saline gauze, keep the patient NPO, and take them urgently to the OR — not bedside repacking and not a CT scan first.
• Fever within 24 hours with a wound that looks angry points to Streptococcus pyogenes or Clostridium perfringens, not routine atelectasis; open and inspect the wound. Pain out of proportion, crepitus, or dishwater fluid means necrotizing infection and immediate debridement — imaging must not delay surgery.
• The vitamin association examiners love: vitamin C is the cofactor for prolyl/lysyl hydroxylase, so deficiency yields under-hydroxylated, unstable collagen — perifollicular hemorrhage, bleeding gums, and old wounds reopening. Copper (lysyl oxidase cross-linking) and zinc (metalloproteinase cofactor) are the runner-ups.
• Keloid extends beyond the original wound margins and does not regress; hypertrophic scar stays within them and often flattens over a year or two. Keloids favor earlobes, chest, and shoulders and recur after simple excision — intralesional corticosteroid is the standard first move, not the scalpel alone.
• Wounds never regain full strength: roughly half of final strength by three weeks and a plateau near four-fifths of intact skin. Type III collagen laid down early is replaced by type I during remodeling — the ratio shifts, the total collagen does not keep climbing.
• Prophylactic antibiotics belong within the hour before incision (longer infusion window for vancomycin and fluoroquinolones) per the CDC 2017 SSI guideline, and are stopped after skin closure; prolonged postoperative courses add C. difficile risk without lowering SSI.
• Common distractors: clip hair, never shave with a razor; erythema and serous drainage in the first 48 hours are inflammation, not infection; and an uncomplicated wound abscess is treated by incision and drainage, with antibiotics added for cellulitis, systemic signs, or immunocompromise (IDSA).